DR. LOUIS DEGENNARO, PRESIDENT AND CHIEF EXECUTIVE OFFICER OF THE LEUKEMIA & LYMPHOMA SOCIETY, EXPLAINS HOW ADVANCES IN BLOOD CANCER HAVE IMPROVED TREATMENT IN OTHER CANCERS.

DR. LOUIS DEGENNARO, PRESIDENT AND CHIEF EXECUTIVE OFFICER OF THE LEUKEMIA & LYMPHOMA SOCIETY, EXPLAINS HOW ADVANCES IN BLOOD CANCER HAVE IMPROVED TREATMENT IN OTHER CANCERS.

DR. LOUIS DEGENNARO, PRESIDENT AND CHIEF EXECUTIVE OFFICER OF THE LEUKEMIA & LYMPHOMA SOCIETY, EXPLAINS HOW ADVANCES IN BLOOD CANCER HAVE IMPROVED TREATMENT IN OTHER CANCERS.